FTC, FDA Warn Companies about Marketing and Selling Opioid Cessation Products

The Federal Trade Commission and the U.S. Food and Drug Administration (FDA) today posted warning letters to 11 marketers and distributors of opioid cessation products for illegally marketing products with unproven claims about their ability to help in the treatment of opioid addiction and withdrawal.

https://www.ftc.gov/news-events/press-releases/2018/01/ftc-fda-warn-companies-ab...

Source: NCCAM Featured Content - January 26, 2018 Category: Complementary Medicine Authors: NCCIH Source Type: news

More News: Addiction | Complementary Medicine | Food and Drug Administration (FDA) | Marketing | Warnings